Solutions Spotlight

Corning Life Sciences Solutions Spotlight Presentation: Rock the Science of 3D: From Promise to Reality

Tuesday, February 6
4:00 PM - 4:20 PM
Location: Exhibition Theater

3D cell culture is exploding. Life-like models that have never before been possible are becoming a reality in the hands of innovative scientists around the world. Hear Richard Eglen, Corning Life Sciences Vice President and General Manager, review some of the most ground-breaking research in the space and discuss the exciting promise of 3D in the future as it relates to drug screening.

Send Email for Caitlin Fitch

Richard M. Eglen

Vice President and General Manager
Corning Life Sciences

Dr. Richard Eglen joined Corning in 2011 with over 33 years’ experience in the Life Science industry, most recently with PerkinElmer where he was president of Bio-discovery and prior to that vice president and general manager of Drug Discovery Reagents.

Prior to joining PerkinElmer, Richard held numerous executive management positions in the pharmaceutical, diagnostic, and biotech industries. Until 2006, he was executive vice president for Research and Development at DiscoveRx Corp (now part of Eurofins Pharma Discovery Services). He also served as vice president of the Center for Biological Research at Roche.

Richard has worked extensively in the GPCR, kinase, and ion channel fields, as well as in assay and instrument technology development for high-throughput screening, imaging, and biomarker detection. He has authored more than 320 publications, book chapters, and patents, and serves on numerous industry, academic advisory, and journal editorial boards.

Richard received his Bachelor of Science degree in Special Honours Physiology from Sheffield University, UK and a Ph.D. in Molecular Pharmacology from Trent University, UK.

Since joining Corning Life Sciences in 2011, Richard has been responsible for setting the strategic direction for the division’s growth. This growth included the acquisitions of Mediatech Inc. in 2011, Becton Dickinson’s Discovery Labware business in 2012 and VACCA Biologics in 2017.

Richard has also led the geographic expansion of the division, particularly in Asia Pacific, where CLS has invested in new manufacturing and distribution facilities to support regional growth. Richard has used his extensive knowledge to elevate and position Corning Life Sciences within the industry, helping create strong partnerships and collaborations that allow the division to outperform the market and stay at the forefront of new product development.

Presentation(s):

Send Email for Richard Eglen


Assets

Corning Life Sciences Solutions Spotlight Presentation: Rock the Science of 3D: From Promise to Reality

Slides

Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for Corning Life Sciences Solutions Spotlight Presentation: Rock the Science of 3D: From Promise to Reality